A prognostic score for overall survival in patients treated with abiraterone in the pre- and post-chemotherapy setting
Metrics: PDF 397 views | Full Text 653 views | ?
Martin Boegemann1, Katrin Schlack1, Lena Früchtenicht1, Julie Steinestel2, Andres Jan Schrader1, Yvonne Wennmann1, Laura-Maria Krabbe1,3 and Okyaz Eminaga4
1 Department of Urology, University of Muenster Medical Center, Muenster, Germany
2 Department of Urology, Augsburg Medical Center, Augburg, Germany
3 Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA
4 Department of Urology, Stanford Medical School, Stanford, CA, USA
Keywords: risk score; mCRPC; abiraterone; survival; outcome
Received: March 13, 2019 Accepted: July 21, 2019 Published: August 20, 2019
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.